Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamyd for Prevention of Type 1 Diabetes in Children
NCT01122446Phase 2Completed
- Sponsor
- Lund University
- Start
- Apr 2009
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Diamyd in type 1 diabetes mellitus (T1D), sponsored by Lund University. Started Apr 2009; status: completed.
02
Drugs
Diamyd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01122446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122446.